Abstract
The ATM gene (mutated in the disease ataxia telangiectasia) activates the p53 tumor suppressor protein in response to DNA damage, explaining the higher incidence of cancer in AT patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749– 1753 (1995).
Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674–1677 (1998).
Canman, C.E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677– 1679 (1998).
Savitsky, K. et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4, 2025–2032 (1995).
Kastan, M.B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71, 587–597 (1992).
Shieh, S.-Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334 (1997).
Woo, R.A., McLure, K.G., Lees-Miller, S.P., Rancourt D.E. & Lee. P.W.K. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394 , 700–705 (1998).
Ko, L.J. et al. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol. Cell. Biol. 17, 7220– 7229 (1997).
Waterman, M.J., Stavridi, E.S., Waterman J.L.F. & Halazonetis T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genet. 19, 175–178 (1998).
Lu, H., Taya, Y., Ikeda, M. & Levine A.J. Ultraviolet radiation, but not γ-irradiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine 389. Proc. Natl. Acad. Sci. USA 95, 6399–6402 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, Y. ATM: the p53 booster . Nat Med 4, 1231–1232 (1998). https://doi.org/10.1038/3207
Issue Date:
DOI: https://doi.org/10.1038/3207
This article is cited by
-
DNA damage repair and cancer immunotherapy
Genome Instability & Disease (2023)
-
TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation
Virchows Archiv (2019)
-
Sterigmatocystin induces G1 arrest in primary human esophageal epithelial cells but induces G2 arrest in immortalized cells: key mechanistic differences in these two models
Archives of Toxicology (2015)
-
Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background
Oncogene (2008)
-
Recombination and its roles in DNA repair, cellular immortalization and cancer
AGE (1999)